Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
15.87
0.70 (4.61%)
At close: Jun 06, 2025, 3:10 PM

Benitec Biopharma Statistics

Share Statistics

Benitec Biopharma has 25.6M shares outstanding. The number of shares has increased by 172.16% in one year.

25.6M
172.16%
9.81%
86.06%
n/a
1,546
3.18%

Short Selling Information

The latest short interest is 439.2K, so 1.72% of the outstanding shares have been sold short.

439.2K
1.72%
3.21%
11.85

Valuation Ratios

The PE ratio is -3.43 and the forward PE ratio is -6.21. Benitec Biopharma's PEG ratio is 0.04.

-3.43
-6.21
344.9
2.7
1.58
-3.8
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Benitec Biopharma.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 10.49, with a Debt / Equity ratio of 0.01.

10.49
10.49
0.01
-0.01
-0.01
-24.88

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$13,500
$-1,359,437.5
16
0
n/a

Taxes

-619K
2.77%

Stock Price Statistics

The stock price has increased by 107.49% in the last 52 weeks. The beta is 0.44, so Benitec Biopharma's price volatility has been higher than the market average.

0.44
107.49%
13.71
11.57
57.73
48,688

Income Statement

In the last 12 months, Benitec Biopharma had revenue of 216K and earned -21.75M in profits. Earnings per share was -2.68.

216K
108K
-22.49M
-21.75M
-22.49M
-21.75M
-2.68
Full Income Statement

Balance Sheet

The company has 50.87M in cash and 284K in debt, giving a net cash position of 50.58M.

50.87M
284K
50.58M
-190.26M
105.21M
96.98M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.4M and capital expenditures -179K, giving a free cash flow of -19.58M.

-19.4M
-179K
-19.58M
-1.91
Full Cash Flow Statement

Margins

Gross margin is 50%, with operating and profit margins of -10412.04% and -10069.91%.

50%
-10412.04%
-10356.48%
-10069.91%
-10412.04%
-10412.04%
-9065.74%

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BNTC is $24, which is 54.6% higher than the current price. The consensus rating is "Buy".

$24
54.6%
Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jul 26, 2023. It was a backward split with a ratio of 1:17.

Jul 26, 2023
backward
1:17

Scores

29.79
2